Your institution may have access to this item. Find your institution then sign in to continue.
Title
Omission Possible: Nobelpharma v. Implant Innovations Makes Material Omissions in Patent Applications a Possible Source of Liability for Antitrust Counterclaims.
Explains patent infringement and antitrust counterclaim issues raised by the lawsuit filed in the United States by Nobelpharma AB against Implant Innovations Inc. Highlights of the decision's new avenue for liability in antitrust counterclaims to patent infringement; Outlines of antitrust liability standards.